Tag:

David Heimbrook

Latest Headlines

Latest Headlines

Roche oncology chief sees big impact of sugar tech

June 25, 2008
Three years after plunking down $180 million to buy GlycArt, Roche says the sugar-related technology it acquired in the deal is demonstrating striking effectiveness enhancing experimental cancer

Related Tags

Press Releases

Featured Jobs